Key Points Systemic Light Chain Amyloidosis Immunoglobulin light chain (AL) amyloidosis
is a rare disease that occurs when a plasma cell disorder produces monoclonal light chains …

Amyloidosis affects millions of people, as a cause of Alzheimer's disease or a complication
of dialysis, and also causes rare conditions. The many forms of the disorder have one …

The amyloid-β peptide (Aβ) is a key protein in Alzheimer's disease (AD) pathology. We
previously reported in vitro evidence suggesting that Aβ is an antimicrobial peptide. We …

Background: Transthyretin amyloidosis (ATTR) is a heterogeneous disorder with multiorgan
involvement and a genetic or nongenetic basis. Objectives: The goal of this study was to …

Background—The prognosis and treatment of the 2 main types of cardiac amyloidosis,
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …

Objectives This study aimed to assess the diagnostic use of native T1 to detect cardiac
amyloidosis (CA) in a large prospective cohort of patients referred for suspected systemic …

Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related
to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging …

Abstract In 2008, The ESC Working Group on Myocardial and Pericardial Diseases
proposed an updated classification of cardiomyopathies based on morphological and …

Background—Most studies of amyloidotic cardiomyopathy consider as a single entity the 3
main systemic cardiac amyloidoses: acquired monoclonal immunoglobulin light-chain (AL); …

Background: Prognosis in light-chain (AL) and transthyretin (ATTR) amyloidosis is
influenced by cardiac involvement. ATTR amyloidosis has better prognosis than AL …